{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:34:44Z","timestamp":1772148884576,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Reumatikerfonden"},{"DOI":"10.13039\/501100005760","name":"G\u00f6teborgs Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1376-z","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T08:55:18Z","timestamp":1500886518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"A. J.","family":"Landgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. T. H.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Z. S.","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Drivelegka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fjellstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dehlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"issue":"4","key":"1376_CR1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1376_CR2","doi-asserted-by":"crossref","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136\u201341.","DOI":"10.1002\/art.30520"},{"issue":"2","key":"1376_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","volume":"40","author":"E Roddy","year":"2014","unstructured":"Roddy E, Choi HK. Epidemiology of gout. Rheum Dis Clin N Am. 2014;40(2):155\u201375.","journal-title":"Rheum Dis Clin N Am"},{"issue":"1","key":"1376_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-016-1062-6","volume":"18","author":"M Dehlin","year":"2016","unstructured":"Dehlin M, Drivelegka P, Sigurdardottir V, Sv\u00e4rd A, Jacobsson LTH. Incidence and prevalence of gout in Western Sweden. Arthritis Res Ther. 2016;18(1):1\u20137.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1376_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/ajkd.2002.33911","volume":"40","author":"HM Kramer","year":"2002","unstructured":"Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis. 2002;40(1):37\u201342.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1376_CR6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0272-6386(12)80602-0","volume":"18","author":"CY Pak","year":"1991","unstructured":"Pak CY. Etiology and treatment of urolithiasis. Am J Kidney Dis. 1991;18(6):624\u201337.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1376_CR7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.7326\/0003-4819-67-6-1133","volume":"67","author":"T Yu","year":"1967","unstructured":"Yu T, Gutman AB. Uric acid nephrolithiasis in gout. Predisposing factors. Ann Intern Med. 1967;67(6):1133\u201348.","journal-title":"Ann Intern Med."},{"key":"1376_CR8","doi-asserted-by":"crossref","unstructured":"Lieske JC, Pena de la Vega SL, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69(4):760\u20134.","DOI":"10.1038\/sj.ki.5000150"},{"issue":"Suppl 1","key":"1376_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000076582","volume":"72","author":"M Amato","year":"2004","unstructured":"Amato M, Lusini ML, Nelli F. Epidemiology of nephrolithiasis today. Urol Int. 2004;72 Suppl 1:1\u20135.","journal-title":"Urol Int."},{"issue":"2","key":"1376_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.urology.2007.09.034","volume":"71","author":"T Yasui","year":"2008","unstructured":"Yasui T, Iguchi M, Suzuki S, Kohri K. Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology. 2008;71(2):209\u201313.","journal-title":"Urology"},{"issue":"2-3","key":"1376_CR11","first-page":"e86","volume":"12","author":"V Romero","year":"2010","unstructured":"Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2-3):e86\u201396.","journal-title":"Rev Urol"},{"issue":"3","key":"1376_CR12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1046\/j.1523-1755.2003.t01-2-00171.x","volume":"64","author":"HJ Kramer","year":"2003","unstructured":"Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolithiasis in men: The Health Professionals' Follow-Up Study. Kidney Int. 2003;64(3):1022\u20136.","journal-title":"Kidney Int"},{"issue":"4 Pt 1","key":"1376_CR13","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0022-5347(05)64439-4","volume":"168","author":"B Shekarriz","year":"2002","unstructured":"Shekarriz B, Stoller ML. Uric acid nephrolithiasis: current concepts and controversies. J Urol. 2002;168(4 Pt 1):1307\u201314.","journal-title":"J Urol"},{"issue":"5","key":"1376_CR14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ki.1978.60","volume":"13","author":"FL Coe","year":"1978","unstructured":"Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978;13(5):418\u201326.","journal-title":"Kidney Int"},{"issue":"4","key":"1376_CR15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0002-9343(78)90846-X","volume":"65","author":"CY Pak","year":"1978","unstructured":"Pak CY, Barilla DE, Holt K, Brinkley L, Tolentino R, Zerwekh JE. Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis. Am J Med. 1978;65(4):593\u20139.","journal-title":"Am J Med"},{"issue":"6","key":"1376_CR16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s40620-014-0084-x","volume":"27","author":"O Arowojolu","year":"2014","unstructured":"Arowojolu O, Goldfarb DS. Treatment of calcium nephrolithiasis in the patient with hyperuricosuria. J Nephrol. 2014;27(6):601\u20135.","journal-title":"J Nephrol"},{"issue":"4","key":"1376_CR17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002708","volume":"73","author":"GC Curhan","year":"2008","unstructured":"Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int. 2008;73(4):489\u201396.","journal-title":"Kidney Int"},{"issue":"4","key":"1376_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/14656566.2013.775250","volume":"14","author":"H Xu","year":"2013","unstructured":"Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013;14(4):435\u201347.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"1376_CR19","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1046\/j.1523-1755.2003.00917.x","volume":"63","author":"KK Stamatelou","year":"2003","unstructured":"Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817\u201323.","journal-title":"Kidney Int"},{"issue":"3","key":"1376_CR20","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1523-1755.2005.00516.x","volume":"68","author":"EN Taylor","year":"2005","unstructured":"Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68(3):1230\u20135.","journal-title":"Kidney Int"},{"issue":"6","key":"1376_CR21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2015.254","volume":"88","author":"AL Zisman","year":"2015","unstructured":"Zisman AL, Evan AP, Coe FL, Worcester EM. Do kidney stone formers have a kidney disease? Kidney Int. 2015;88(6):1240\u20139.","journal-title":"Kidney Int"},{"issue":"11","key":"1376_CR22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649\u201362.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"1376_CR23","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1046\/j.1523-1755.1999.00739.x","volume":"56","author":"S Shahinfar","year":"1999","unstructured":"Shahinfar S, Simpson RL, Carides AD, Thiyagarajan B, Nakagawa Y, Umans JG, Parks JH, Coe FL. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int. 1999;56(5):1879\u201385.","journal-title":"Kidney Int"},{"issue":"4","key":"1376_CR24","first-page":"227","volume":"5","author":"BR Matlaga","year":"2003","unstructured":"Matlaga BR, Shah OD, Assimos DG. Drug-induced urinary calculi. Rev Urol. 2003;5(4):227\u201331.","journal-title":"Rev Urol"},{"issue":"1","key":"1376_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2010.10.033","volume":"156","author":"CS Lin","year":"2012","unstructured":"Lin CS, Lee WL, Hung YJ, Lee DY, Chen KF, Chi WC, Chang SC. Prevalence of hyperuricemia and its association with antihypertensive treatment in hypertensive patients in Taiwan. Int J Cardiol. 2012;156(1):41\u20136.","journal-title":"Int J Cardiol"},{"key":"1376_CR26","doi-asserted-by":"crossref","unstructured":"Choi HK, Soriano LC, Zhang Y, Rodriguez LA. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study. BMJ (Clinical research ed). 2012;344:d8190.","DOI":"10.1136\/bmj.d8190"},{"issue":"4","key":"1376_CR27","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ahj.2004.04.005","volume":"148","author":"HJ Milionis","year":"2004","unstructured":"Milionis HJ, Kakafika AI, Tsouli SG, Athyros VG, Bairaktari ET, Seferiadis KI, Elisaf MS. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004;148(4):635\u201340.","journal-title":"Am Heart J"},{"issue":"1","key":"1376_CR28","first-page":"73","volume":"7","author":"C Harvengt","year":"1980","unstructured":"Harvengt C, Heller F, Desager JP. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias. Artery. 1980;7(1):73\u201382.","journal-title":"Artery"},{"key":"1376_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.phrs.2015.09.012","volume":"102","author":"G Derosa","year":"2015","unstructured":"Derosa G, Maffioli P, Sahebkar A. Plasma uric acid concentrations are reduced by fenofibrate: a systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacol Res. 2015;102:63\u201370.","journal-title":"Pharmacol Res."},{"key":"1376_CR30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-015-0610-9","volume":"17","author":"MJ Roughley","year":"2015","unstructured":"Roughley MJ, Belcher J, Mallen CD, Roddy E. Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther. 2015;17:90.","journal-title":"Arthritis Res Ther."},{"key":"1376_CR31","unstructured":"Statistiska C. Folkm\u00e4ngden efter region, civilst\u00e5nd, \u00e5lder och k\u00f6n. \u00c5r 1968 - 2014 \nwww.scb.se\n\n. 2012."},{"key":"1376_CR32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health."},{"issue":"1","key":"1376_CR33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","volume":"75","author":"CF Kuo","year":"2016","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis. 2016;75(1):210\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1376_CR34","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.juro.2012.09.102","volume":"189","author":"GS Marchini","year":"2013","unstructured":"Marchini GS, Sarkissian C, Tian D, Gebreselassie S, Monga M. Gout, stone composition and urinary stone risk: a matched case comparative study. J Urol. 2013;189(4):1334\u20139.","journal-title":"J Urol"},{"issue":"22","key":"1376_CR35","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM198611273152204","volume":"315","author":"B Ettinger","year":"1986","unstructured":"Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315(22):1386\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"1376_CR36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-016-1211-y","volume":"19","author":"M Dehlin","year":"2017","unstructured":"Dehlin M, Ekstrom EH, Petzold M, Stromberg U, Telg G, Jacobsson LT. Factors associated with initiation and persistence of urate-lowering therapy. Arthritis Res Ther. 2017;19(1):6.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1376_CR37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990\u20131999. Ann Rheum Dis. 2005;64(2):267.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1376_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-015-0522-8","volume":"17","author":"C-F Kuo","year":"2015","unstructured":"Kuo C-F, Grainge MJ, See L-C, Yu K-H, Luo S-F, Zhang W, Doherty M. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther. 2015;17(1):13.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"1376_CR39","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2215\/CJN.04670510","volume":"5","author":"RF Reilly","year":"2010","unstructured":"Reilly RF, Peixoto AJ, Desir GV. The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis. Clin J Am Soc Nephrol. 2010;5(10):1893\u2013903.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1376_CR40","first-page":"397","volume":"19","author":"A Zomorrodi","year":"2008","unstructured":"Zomorrodi A, Golivandan J, Samady J. Effect of diuretics on ureteral stone therapy with extracorporeal shock wave lithotripsy. Saudi J Kidney Dis Transpl. 2008;19(3):397\u2013400.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1376_CR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12891-015-0614-2","volume":"16","author":"M Dehlin","year":"2015","unstructured":"Dehlin M, Stasinopoulou K, Jacobsson L. Validity of gout diagnosis in Swedish primary and secondary care - a validation study. BMC Musculoskelet Disord. 2015;16:149.","journal-title":"BMC Musculoskelet Disord."},{"issue":"11","key":"1376_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113602","volume":"9","author":"AK Jakobsen","year":"2014","unstructured":"Jakobsen AK, Jacobsson LT, Patschan O, Askling J, Kristensen LE. Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects. PLoS One. 2014;9(11), e113602.","journal-title":"PLoS One"},{"issue":"5","key":"1376_CR43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7861\/clinmedicine.12-5-467","volume":"12","author":"CH Dawson","year":"2012","unstructured":"Dawson CH, Tomson CR. Kidney stone disease: pathophysiology, investigation and medical treatment. Clin Med (Lond). 2012;12(5):467\u201371.","journal-title":"Clin Med (Lond)"},{"key":"1376_CR44","doi-asserted-by":"crossref","unstructured":"Moe OW. Kidney stones: pathophysiology and medical management. Lancet (London, England). 2006;367(9507):333\u201344.","DOI":"10.1016\/S0140-6736(06)68071-9"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1376-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T08:56:30Z","timestamp":1500886590000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1376-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1376-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"article-number":"173"}}